![Patrik Ringblom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrik Ringblom
Directeur/Bestuurslid bij
SPECTRACURE AB
Profiel
Patrik Ringblom is currently an Independent Director at SpectraCure AB since 2025 and Head-Strategy & US Lead at Lakefront Biotherapeutics since 2023.
Formerly, Mr. Ringblom was VP-Rare Disease Novel Therapeutics & Alliance at Johnson & Johnson from 2022 to 2023.
Mr. Ringblom completed an MBA at Handelshögskolan i Göteborg.
Actieve functies van Patrik Ringblom
| Bedrijven | Functie | Begin |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Corporate Officer/Principal | 01-10-2023 |
| SPECTRACURE AB | Directeur/Bestuurslid | 01-01-2025 |
Eerdere bekende functies van Patrik Ringblom
| Bedrijven | Functie | Einde |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01-10-2023 |
Opleiding van Patrik Ringblom
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
47
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
SpectraCure AB
 SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment | Electronic Technology |
Handelshögskolan i Göteborg
 Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
